Legal Opinion
To: Chengdu Kanghong Pharmaceutical Group Co., Ltd.
This legal opinion is issued based on the authorization of the company and in accordance with the "Company Law," "Securities Law," "Administrative Measures," and other relevant laws and regulations.
1. Approval and Authorization of This Adjustment
On June 18, 2021, the company convened the seventh meeting of the board of directors, which approved the proposal regarding the "2021 Stock Option Incentive Plan" and the related resolutions.
On June 21, 2021, the company convened the first extraordinary general meeting of shareholders, which approved the proposal regarding the "2021 Stock Option Incentive Plan."